Uganda is set to introduce a new long-acting HIV prevention drug, Lenacapavir, in 2026 under a United States-funded ...
A federal grant for HIV research is part of $15.7 million the National Institutes for Health awarded to the Wertheim UF ...
ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine platform targeting Alzheimer's disease. Current ...
Healthbeat on MSN
Deal to lower price for new HIV prevention shot is ‘huge moment of hope’ in global health
This is the Global Health Checkup, five of the week’s most important stories on outbreaks, medicine, science, and survival from around the world. This week: a breakthrough on the price of a new HIV ...
Secure, scalable, multi-cloud platform using federated learning aims to accelerate cancer discoveries and treatments SEATTLE, WASHINGTON / ACCESS Newswire / October 1, 2025 / The Cancer AI Alliance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback